Recall report: Glass found in Merck antibiotic threatens 22,000 vials
A Merck antibiotic has been recalled after reports of the presence of glass particulate matter, the company announced Tuesday.
One lot of Cubicin will be recalled, which includes about 22,000 vials of the 500mg dose of the intravenously administered drug.
The recall comes after a piece of glass was found in a vial, raising safety concerns.
“Our highest priorities are the health and safety of patients and the quality of our medicines and vaccines,” said Richard Haupt, the VP of vaccines & infectious diseases. “We sincerely regret any inconvenience caused by this recall.”
Cubicin treats skin infections in both adults and children, and Staphylococcus aureus infections in children, and is packaged in single-dose, 10 mL glass vials.
Merck is arranging for the return of the products via UPS Next Day Air.
The FDA has been notified of the recall, Merck said, though the FDA on Wednesday posted the notice to its recall page.
Separately, one lot of Bryant Ranch Prepack’s muscle relaxers have been recalled as well. The California-based company is recalling 30- and 90-count bottles of methocarbamol 500mg after some packages of 500mg tablets were found to contain 750mg tablets.
If a patient were to take a 750mg tablet, that could lead to excessive central nervous system depression, which results in nausea, sedation, fainting, seizures and comas. So far, there have not been any reports of side effects resulting from the recall.
The product can be identified by its red and white label with a yellow border at the top and bottom of the packaging. The drug was distributed across the country.